Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Sudden death; This is a spontaneous report from a contactable Physician downloaded from the Agency Regulatory Authority-WEB. The Regulatory Authority report number is FR-AFSSAPS-BX20212598. An 89-year-old female patient received the first dose of BNT162B2 (COMIRNATY, Lot Number: ET3620 and expiration date not reported), intramuscular, administered in the left arm on 26Mar2021 as a single dose for COVID-19 immunisation. Medical history included Type 2 diabetes mellitus, Depression, Overweight, Hypertension; all from an unknown date and unknown if ongoing. Concomitant medications included metformin (METFORMINE), bisoprolol fumarate (CARDENSIEL), alprazolam, and sertraline hydrochloride (ZOLOFT). The patient is autonomous at home and went to bed around 8:30 pm to 9 p.m. On 27Mar2021, the patient experienced sudden death. Presence of a basin next to the bed and there was no sign of struggle. The patient died on 27Mar2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Sudden death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166